Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 46Lung Neoplasms 29Neoplasms 26Colorectal Neoplasms 21Prostatic Neoplasms 16Uterine Cervical Neoplasms 9Fatigue 9Hematologic Neoplasms 8Lymphoma 7Hematopoietic and Lymphatic System Neoplasm 7Anxiety Disorders 7Papillomavirus Infections 6Melanoma 6Neoplasm Metastasis 5Multiple Myeloma 5Gastrointestinal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Skin Neoplasms 4Ovarian Neoplasms 4Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Depression 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3

Interventions

Pioglitazone 4Sitagliptin Phosphate 3Resistance Training 3Vildagliptin 2Sulfonylurea Compounds 2Nutritional Status 2Metformin 2Dipeptidyl-Peptidase IV Inhibitors 2Blood Specimen Collection 2voglibose 1saxagliptin 1repaglinide 1miglitol 1metahexamide 1meglitinide 1mazdutide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1alogliptin 1Urine Specimen Collection 1Troglitazone 1Tolbutamide 1Tolazamide 1Thiazolidinediones 1Surveys and Questionnaires 1Sodium-Glucose Transporter 2 Inhibitors 1Rosiglitazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus, Type 2 × Educational Status × Clear all
NCT04938869 2023-02-24

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡